Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation
about
Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapiesIs lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells?Mutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomasControl of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic targetLymphoma: immune evasion strategiesCrebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice.Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis.New developments in the pathology of malignant lymphoma: a review of literature published from January 2015 to April 2015.Microenvironment abnormalities and lymphomagenesis: Immunological aspects.Activation induced deaminase mutational signature overlaps with CpG methylation sites in follicular lymphoma and other cancers.Cancer immunotherapy: Strategies for personalization and combinatorial approaches.Targetable genetic features of primary testicular and primary central nervous system lymphomas.The 2016 revision of the World Health Organization classification of lymphoid neoplasms.Large-scale microarray profiling reveals four stages of immune escape in non-Hodgkin lymphomas.Epigenetics of hematopoiesis and hematological malignancies.Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors.Integrative whole-genome sequence analysis reveals roles of regulatory mutations in BCL6 and BCL2 in follicular lymphomaClinical Impact of the 2016 Update to the WHO Lymphoma Classification.Genetic landscape and deregulated pathways in B-cell lymphoid malignancies.High-throughput sequencing for noninvasive disease detection in hematologic malignancies.Epigenetic dysregulation in follicular lymphoma.Mechanisms of Immune Tolerance in Leukemia and Lymphoma.Inactivation of CREBBP expands the germinal center B cell compartment, down-regulates MHCII expression and promotes DLBCL growth.CREBBP knockdown enhances RAS/RAF/MEK/ERK signaling in Ras pathway mutated acute lymphoblastic leukemia but does not modulate chemotherapeutic response.Catalog of genetic progression of human cancers: non-Hodgkin lymphoma.New targeted therapies for malignant lymphoma based on molecular heterogeneity.Oncogenic events rather than antigen selection pressure may be the main driving forces for relapse in diffuse large B-cell lymphomas.High-throughput genomic profiling of tumor-infiltrating leukocytes.Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells.Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations.Follicular lymphoma: State-of-the-art ICML workshop in Lugano 2015.Early stages in the ontogeny of small B-cell lymphomas: genetics and microenvironment.Mechanisms of PD-1/PD-L1 expression and prognostic relevance in non-Hodgkin lymphoma: a summary of immunohistochemical studies.Recurrent Mutations in the MTOR Regulator RRAGC in Follicular Lymphoma.Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene.Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma.Deltex-1 mutations predict poor survival in diffuse large B-cell lymphoma.High-risk follicular lymphomas harbour more somatic mutations including those in the AID-motif
P2860
Q26744080-6F70A1D4-F2C8-4FBE-A3F0-EA39611F376CQ26779702-59CCF741-0A8C-40B9-BD49-62966FC9F616Q26782506-A0DCBF55-C394-40A3-AEC3-370D62FB2D55Q28070887-B8EF7967-C8DD-4D70-9C7F-0D91B066A407Q28080705-3985FE78-E2D6-476B-AC77-866FEBFC9B0CQ33671971-3EAF2F44-B806-4281-A9EB-4D2C8836428CQ33851726-1DB16439-14C8-4616-BFD9-3FEF17A54C5AQ34494007-BE018E80-EC2B-41A9-BB45-B8B29B5965EEQ35783447-44552D66-87A9-42AE-A95D-A97A9BFFA112Q36118020-0657368F-DD70-46A1-903E-21CAB36B4CA6Q36214679-28C2B3B0-10D3-4E94-9EA4-C50981B6C4DCQ36387028-C65AA305-BF32-46B0-A093-E1E9A8C25915Q36596879-28A86194-60F3-4054-B467-1B2DF6309963Q36920426-3A20DF3D-24BC-471E-B4F4-5D842A0050BDQ37222108-0DDDA172-242E-4E4A-B463-9EF536AEC4CDQ37343797-FB9450CF-1502-4024-A1A3-2A4DF2C688CAQ37609908-5969DA57-A3F8-4367-953B-5A3EB458F0DEQ38616272-15DBA633-4F55-431A-B609-0814610F93F9Q38647938-81A110BE-D8AE-41DF-9477-08BC49481C6AQ38663689-23E23175-FFC3-4991-AB3F-966AB14A9848Q38669131-AAE098AC-EB2B-461F-B674-98007C573DB7Q38672646-8E98F5CC-0FB2-40D1-AEFC-E439D2582E93Q38677466-06CFA808-8EC9-4BD7-8EE2-B5F4826AD0A4Q38683034-0FE1D700-14BA-4A24-A02B-095D59E8F75BQ38694379-3BE38681-77C4-4588-AC79-67ABDE3D5535Q38726062-C4610A64-6864-44AC-9C05-9B9DD8B8FEC2Q38766227-5965D99B-3317-4A73-A2CC-6EB1DA8183D3Q38787141-88D7B76D-8F0D-410E-8312-05A8440F1CA4Q38811964-85A2E2E1-E90B-4F4E-93CC-6A621A8C3B9FQ38884388-A82ED701-132E-4CA4-94BB-F84394768506Q38889427-5AF70E66-D93B-4F42-A0B5-C4944EB980DCQ39096389-5E429085-F012-4E53-A20C-1E938DD8BA1DQ39221094-8FA35A66-E4B5-40E8-85DB-A7EBB48208D9Q39230986-654175C3-C798-4301-AFEE-4F5864DB6185Q39237785-597B337A-5F40-40DE-B699-B879F89EF2A9Q39706167-B6EF1AAF-9C30-4700-B0C8-F62CAC556C88Q40953476-03FF841A-3333-45E3-AEFD-C79B426DBC3FQ41438291-29D84577-25B7-4736-8082-CA4A0BB6E22FQ42336333-998F9957-7D3F-48C5-8E38-720237D9C22EQ42630555-F4D4E52F-0AD0-4F4D-A55C-BE7C8D241710
P2860
Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Mutations in early follicular ...... uppressed antigen presentation
@ast
Mutations in early follicular ...... uppressed antigen presentation
@en
type
label
Mutations in early follicular ...... uppressed antigen presentation
@ast
Mutations in early follicular ...... uppressed antigen presentation
@en
prefLabel
Mutations in early follicular ...... uppressed antigen presentation
@ast
Mutations in early follicular ...... uppressed antigen presentation
@en
P2093
P2860
P50
P356
P1476
Mutations in early follicular ...... uppressed antigen presentation
@en
P2093
Andrew J Gentles
Chih Long Liu
Daniel A Arber
Henning Stehr
Isabel Romero-Camarero
Raheleh Salari
Ramesh V Nair
Ronald Levy
Serafim Batzoglou
Sylvia K Plevritis
P2860
P304
P356
10.1073/PNAS.1501199112
P407
P577
2015-02-23T00:00:00Z